Publication - Peptide synthesis-Cosmetic peptides-Peptide CMO-Cellmano Biotech Limited

Position：Home > About Us > Publication

Company
Blogs
Publication

Customer published literature

Since 2011, the Products & Services offered by Cellmano Biotech Limited were sited by many magazines related to chemistry, biology and pharmacy , such as Nature, Science, Cell, PNAS, etc. The customers Cellmano has serviced are located in various countries in Asia, North America, EU . Cellmano provide peptide related products & services constantly to more than one hundred wellknown research organizations, Biotech companies, Pharmaceutical companies and Cosmetic companies ,some like The University of Chicago, The Scripps Research Institute in US and Peking University , Fudan University in China. Some customers are doing their preclinical or clinical research with Cellmano’s peptides involved already. Here are some papers published by customers who used the peptides provided by Cellmano listed for your reference :

Start End

Number/Page

Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine

Products & Service： Custom peptide
Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease

Products & Service： Custom peptide
G37V mutation of Aβ42 induces a nontoxic ellipse-like aggregate: An in vitro and in silico study

Products & Service： Amyloid β 1-42
High-Throughput Stability Screening of Neoantigen/HLA Complexes Improves Immunogenicity Predictions

Products & Service： Custom peptide
Combination drug delivery via multilamellar vesicles enables targeting of tumor cells and tumor vasculature

Products & Service： Custom peptide

首页 1 2 3 4 5 末页

About Us

Customer published literature

Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine

Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease

G37V mutation of Aβ42 induces a nontoxic ellipse-like aggregate: An in vitro and in silico study

High-Throughput Stability Screening of Neoantigen/HLA Complexes Improves Immunogenicity Predictions

Combination drug delivery via multilamellar vesicles enables targeting of tumor cells and tumor vasculature